Abstract
Deacetylated chitin derivatives have been widely studied for tissue engineering purposes. This study aimed to compare the efficacy of an injectable product containing a 50% deacetylated chitin derivative (BoneReg-Inject™) and an existing product (chronOS Inject®) serving as a predicate device. A sheep model with a critical size drill hole in the tibial plateau was used. Holes of 8 mm diameter and 30 mm length were drilled bilaterally into the proximal area of the tibia and BoneReg-Inject™ or chronOS Inject® were injected into the right leg holes. Comparison of resorption and bone formation in vivo was made by X-ray micro-CT and histological evaluation after a live phase of 12 weeks. Long-term effects of BoneReg-Inject™ were studied using a 13-month live period. Significant differences were observed in (1) amount of new bone within implant (p < 0.001), higher in BoneReg-Inject™, (2) signs of cartilage tissue (p = 0.003), more pronounced in BoneReg-Inject™, and (3) signs of fibrous tissue (p < 0.001), less pronounced in BoneReg-Inject™. Mineral content at 13 months postoperative was significantly higher than at 12 weeks (p < 0.001 and p < 0.05, for implant core and rim, respectively). The data demonstrate the potential of deacetylated chitin derivatives to stimulate bone formation.
Original language | English |
---|---|
Article number | 838 |
Journal | Materials |
Volume | 15 |
Issue number | 3 |
DOIs | |
Publication status | Published - 22 Jan 2022 |
Bibliographical note
Funding Information:Funding: This work was supported by the Technology Development Fund, managed by the Icelandic Centre for Research [RAN 090303-0246].
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Other keywords
- Bone defects
- Bone formation
- Bone implant
- Chitosan
- Degree of deacetylation
- Histology
- Sheep tibia
- X-ray micro CT